Cash-Flow King Hold: Is $5,000 a Forever Bet for Markets?
Vertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
We review 2024 tax-efficient index fund options and provide practical guidance for incorporating them into a retirement strategy.
24,809 articlesVertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
A new bipartisan proposal would create a formal commission to study the long-term finances of Social Security and Med...
A career setback in 1998 launched Jamie Dimon's rise to the helm of JPMorgan Chase. This piece draws lessons for pers...
A growing wave of workers relies on AI to interpret messages and draft replies from supervisors, a trend that could s...
A second Dan Sullivan surfaces on Alaska’s August ballot for the U.S. Senate, sparking legal questions and concerns a...
U.S. equity markets tumbled as traders priced in a looming memory supply crisis in chipmakers, triggering a broad tec...
A senior macro investor warns that the global order is entering a perilous stage of the Big Cycle, likely to test mar...
On March 25, 2026, ramsey calls $800k worth behavior sparked a debate about wealth, budgeting, and how much spending ...
The OECD's June 2026 outlook warns of lasting damage to potential output from a protracted energy crisis, outlining t...
A new study shows AI-native startups favor seasoned staff, trimming entry-level roles and altering the career path an...
Eight years in stealth have shaped a new robotics venture from Travis Kalanick, with implications for workers, equity...
OpenAI CEO Sam Altman notes a sharp generational divide in how ChatGPT is used, with Millennials seeking personal fin...